Media Summary: Dave Coppersmith and Myong-Jin Kim from CDER's Office of Generic Drugs provide information on Generic Program 2020 U.S. Food and Drug Administration Generic Program 2020 U.S. Food and Drug Administration. This presentation provided an overview of the FDA
Product Specific Guidances Psgs 3of16 - Detailed Analysis & Overview
Dave Coppersmith and Myong-Jin Kim from CDER's Office of Generic Drugs provide information on Generic Program 2020 U.S. Food and Drug Administration Generic Program 2020 U.S. Food and Drug Administration. This presentation provided an overview of the FDA Mitchell Frost from CDER's Office of Generic Drugs discusses study population and terminology, bioequivalence studies with ... Markham C. Luke from CDER's Office of Generic Drugs discusses Lei Zhang, Deputy Director of the Office of Research and Standards in FDA's Office of Generic Drugs, explains
The purpose of this webinar was to provide current and prospective generic drug applicants insight on how Rob Lionberger, Lei Zhang, CDR Christine Le, Myong-Jin Kim, Markham Luke, Mitchell Frost, Paramjeet Kaur, David Coppersmith ... This presentation described how ongoing research contributes to the evolution of This presentation provided an overview of the U.S FDA Director of the Office of Research and Standards (ORS) Robert Lionberger in the Office of Generic Drugs at CDER provides ... This event offered a comprehensive overview of controlled correspondence as an efficient pathway for communication with the ...
The discussion identified recently developed Amanda Jones, PhD, from the Division of Bioequivalence I (DBI) presents the Regulatory Background Aim and Scope of the ... Kris Andre from CDER's Office of Generic Drugs shares how to interact with FDA prior to submission on complex Christine Le from CDER's Office of Generic Drugs discusses the
